AMENDMENT 
 
TEST TEST TEST This Is a Test from PR NEWSWIRE - Please Ignore 
 
Disclose HTML TEST 2 - Please ignore - Post deployment - test HTML release. 
 
23.05.15 at 20:00 
 
Disclose HTML Test PROD 23.05.15 
 
LONDON 
 
- Curabitur molestie mauris sed dolor dictum iaculis 
 
- Duis dictum, purus in condimentum tincidunt 
 
Curabitur molestie mauris sed dolor dictum iaculis. id viverra urna. Duis 
dictum, purus in condimentum tincidunt, nisl lacus porta diam, sit amet 
suscipit libero est sit amet dui. Lorem ipsum dolor sit amet, consectetur 
adipiscing elit[1]. 
 
  * Mauris est velit, iaculis scelerisque tempus semper, eleifend ac erat. 
  * Duis eu mauris ac risus cursus mattis nec ut erat. Donec fringilla dapibus 
    pharetra. Etiam vitae mi quis dolor mattis adipiscing. Etiam metus arcu, 
    ultrices quis dapibus sed, mollis sit amet nulla. 
  * Maecenas vitae nisl tortor, eu pretium nibh. Nullam nisl dui, vulputate at 
    accumsan nec, volutpat eu urna. 
  * Phasellus mi tellus, varius quis adipiscing sed, euismod id quam. 
  * Praesent quam nisi, feugiat vel accumsan ac, fermentum non libero. 
  * Nam aliquam mollis nibh eu placerat. 
 
Curabitur molestie mauris 
 
Mauris est velit, iaculis scelerisque 
 
(in thousands, except per share amounts) 
 
                                            Three Months Ended     Six Months Ended 
                                                (unaudited)          (unaudited) 
 
                                             June 30,   June 30,   June 30,  June 30, 
                                                 2010       2009       2010      2009 
 
Continuing operations                           $'000      $'000      $'000     $'000 
 
Revenues (see note 4)                         221,125    195,192    415,305   324,971 
 
Cost of revenues (excl.  amortization)       (30,323)   (23,628)   (51,865)  (36,417) 
 
Amortization of purchased intangibles        (14,898)   (15,105)   (29,432)  (20,459) 
 
Total cost of revenues                       (45,221)   (38,733)   (81,297)  (56,876) 
 
Gross profit                                  175,904    156,459    334,008   268,095 
 
Operating expenses: 
 
Research and development                     (27,741)   (28,781)   (55,523)  (48,791) 
 
Sales and marketing                          (50,557)   (37,110)   (93,457)  (65,870) 
 
General and administrative                   (17,264)   (15,508)   (34,519)  (26,796) 
 
Other costs 
 
Post-acquisition restructuring costs            (558)          -      (558)     (846) 
 
(Loss) profit on foreign exchange             (2,777)      (694)        184   (1,127) 
 
Total operating expenses                     (98,897)   (82,093)  (183,873) (143,430) 
 
Profit from operations                         77,007     74,366    150,135   124,665 
 
Share of  loss of associate                     (333)       (85)      (671)     (526) 
 
Interest receivable                             2,178        168      2,985       791 
 
Interest payable                             (11,372)    (2,757)   (16,169)   (3,261) 
 
Profit before income taxes                     67,480     71,692    136,280   121,669 
 
Income taxes                                 (15,129)   (20,817)   (34,215)  (36,278) 
 
Net profit                                     52,351     50,875    102,065    85,391 
 
Basic earnings per share                       $ 0.22     $ 0.21     $ 0.42    $ 0.36 
 
Diluted earnings per share                     $ 0.21     $ 0.21     $ 0.42    $ 0.36 
 
Aenean ligula leo, dignissim volutpat lacinia vel, consectetur in lorem. In 
dignissim quam nec leo sagittis tincidunt scelerisque nunc egestas. Donec 
lobortis interdum magna id congue. Phasellus mattis, turpis ut vulputate 
faucibus, tortor sapien mollis justo, nec vulputate arcu nibh at dolor. Quisque 
tempus, quam sed aliquam interdum, lacus sem elementum justo, nec dictum quam 
ante ac orci. Integer ac nisl eget felis aliquet viverra. Donec lacus enim, 
fringilla ut elementum in, hendrerit sed odio. 
 
Contact: 
 
Morbi diam magna 
 
Ultricies quis facilisis et 
 
Sagittis@neque.com 
 
[1] This is an endnote 
 
 
 
END